• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Avanos Medical Inc.

    3/12/26 4:40:33 PM ET
    $AVNS
    Industrial Specialties
    Health Care
    Get the next $AVNS alert in real time by email
    DEFA14A 1 tm261576d3_defa14a.htm DEFA14A

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934
    (Amendment No.  )

     

     

      

    x   Filed by the Registrant ¨ Filed by a Party other than the Registrant

     

    Check the appropriate box:

     

    Preliminary Proxy Statement

    ¨ CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
    ¨ Definitive Proxy Statement
    x Definitive Additional Materials
    ¨ Soliciting Material Under Rule 14a-12

    ​

    Avanos Medical, Inc.

    ​

    (Name of Registrant as Specified in its Charter)
    (Name of Person(s) Filing Proxy Statement, if Other than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    x No fee required.
    ¨ Fee paid with preliminary materials.
    ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

     

     

     

    GRAPHIC

    Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V87463-P45605 AVANOS MEDICAL, INC. 2026 Annual Meeting Vote by April 20, 2026 11:59 p.m. Eastern Time AVANOS MEDICAL, INC. 5405 WINDWARD PARKWAY ALPHARETTA, GA 30004 You invested in AVANOS MEDICAL, INC. and it’s time to vote! You have the right to vote on the proposals being presented at the 2026 Annual Meeting. This is an important notice regarding the availability of proxy materials for the Annual Meeting of Stockholders to be held on April 21, 2026. Get informed before you vote View the Combined Proxy Statement/2025 Annual Report online OR you can receive a free paper or email copy of the materials by requesting them prior to April 7, 2026. If you would like to request a copy of the materials for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy of the materials. Vote in Person at the Meeting* April 21, 2026 9:00 a.m. Eastern Time 5405 Windward Parkway Alpharetta, GA 30004

    GRAPHIC

    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V87464-P45605 Voting Items Board Recommends THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the 2026 Annual Meeting of Stockholders. Please follow the instructions on the reverse side to vote on these important matters. 1. Election of Directors (to serve until the 2027 Annual Meeting). Nominees: 1a. Gary D. Blackford For 1b. William P. Burke For 1c. James L. Cunniff For 1d. Dr. Lisa Egbuonu-Davis For 1e. Indrani L. Franchini For 1f. Patrick J. O’Leary For 1g. David C. Pacitti For 1h. Dr. Julie Shimer For 2. Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2026. For 3. Advisory vote to approve named executive officer compensation. For 4. Approval of an amendment to the Company’s 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company’s outside directors. For

     

    Get the next $AVNS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVNS

    DatePrice TargetRatingAnalyst
    7/25/2023Overweight → Sector Weight
    KeyBanc Capital Markets
    5/22/2023$31.00Buy
    CL King
    2/24/2022$47.00 → $41.00Overweight
    Keybanc
    1/7/2022$37.00 → $36.00Underweight
    Morgan Stanley
    8/4/2021$45.00 → $41.00Underweight
    Morgan Stanley
    8/4/2021$60.00 → $45.00Overweight → Equal-Weight
    Stephens
    8/4/2021$55.00 → $47.00Overweight
    Keybanc
    More analyst ratings

    $AVNS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference

    ALPHARETTA, Ga., March 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today announced that Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer, will participate in a fireside chat at the 2026 Citizens Life Sciences Conference on Wed., March 11 at approximately 1:05 p.m. Eastern Time. A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.About Avanos Medical, Inc.Avanos Medical, Inc. (NYSE:AVNS) is a medical technology com

    3/2/26 5:28:00 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors

    Enters into Agreement with Bradley L. RadoffALPHARETTA, Ga., Feb. 26, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced that it intends to nominate James ("Jim") L. Cunniff, President and CEO of Electromed, Inc., and William ("Bill") P. Burke, former Executive Vice President, Chief Financial Officer of Haemonetics Corporation, to stand for election as independent directors to the Avanos Board of Directors (the "Board") at the Company's 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting"), subject only to successful completion of customary background checks. In connection with Mr. Cunniff's nomination and Avanos's commitmen

    2/26/26 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results

    Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidanceDelivered full-year organic growth of 6% in strategic segmentsExpanded transformation initiatives expected to deliver $15 to $20 million of incremental annualized savings by the end of 2026ALPHARETTA, Ga., Feb. 24, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported fourth quarter and full-year 2025 results. "I'm very pleased with our fourth quarter and full-year results, which demonstrate meaningful progress on our strategic priorities," said David Pacitti, Avanos' chief

    2/24/26 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Blackford Gary bought $659,300 worth of shares (60,000 units at $10.99), increasing direct ownership by 28% to 91,593 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    8/15/25 12:02:50 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Shimer Julie Ann bought $9,925 worth of shares (500 units at $19.85), increasing direct ownership by 1% to 50,090 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    3/11/24 5:15:37 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Avanos Medical downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Avanos Medical from Overweight to Sector Weight

    7/25/23 6:15:12 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    CL King initiated coverage on Avanos Medical with a new price target

    CL King initiated coverage of Avanos Medical with a rating of Buy and set a new price target of $31.00

    5/22/23 8:52:10 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Keybanc reiterated coverage on Avanos Medical with a new price target

    Keybanc reiterated coverage of Avanos Medical with a rating of Overweight and set a new price target of $41.00 from $47.00 previously

    2/24/22 4:48:01 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    SEC Filings

    View All

    SEC Form DEFA14A filed by Avanos Medical Inc.

    DEFA14A - AVANOS MEDICAL, INC. (0001606498) (Filer)

    3/12/26 4:40:33 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)

    3/12/26 4:39:21 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    SEC Form DEF 14A filed by Avanos Medical Inc.

    DEF 14A - AVANOS MEDICAL, INC. (0001606498) (Filer)

    3/12/26 4:37:47 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Principal Accounting Officer Hurley John Joseph covered exercise/tax liability with 226 shares, decreasing direct ownership by 2% to 11,381 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    3/11/26 2:31:18 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    SVP, Chief Financial Officer Galovan Scott Michael covered exercise/tax liability with 1,119 shares, decreasing direct ownership by 1% to 110,343 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    3/11/26 2:30:37 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Principal Accounting Officer Hurley John Joseph exercised 919 shares at a strike of $13.79 and covered exercise/tax liability with 676 shares, increasing direct ownership by 2% to 11,607 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    3/10/26 9:49:52 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Leadership Updates

    Live Leadership Updates

    View All

    Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. "We are delighted to welcome Maria to our Board of Directors," said Pulse Biosciences' Co-Chairman of the Board Robert W. Duggan. "She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse begins creating and disrupting interventional m

    1/9/26 7:00:00 AM ET
    $AVNS
    $HYPR
    $OFIX
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors

    ALPHARETTA, Ga., Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice president, chief financial officer, effective Aug. 1, 2025. Galovan most recently served as Avanos' senior vice president of strategy and corporate development. His background with the company spans 12 years and is highlighted by a proven track record of leading a number of acquisition and divestiture initiatives. Prior to Avanos, he spent 10 years in a variety of strategy, finance, and M&A

    8/5/25 6:45:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer

    ALPHARETTA, Ga., June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appointment of Camille Chang Gilmore as senior vice president and chief human resources officer. In this role, Gilmore will lead all aspects of Avanos' people strategy, including talent acquisition and development, workforce planning, leadership development and employee experience. Her arrival reflects the company's continued commitment to building a workplace where every employee feels val

    6/9/25 7:15:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Financials

    Live finance-specific insights

    View All

    Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results

    Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidanceDelivered full-year organic growth of 6% in strategic segmentsExpanded transformation initiatives expected to deliver $15 to $20 million of incremental annualized savings by the end of 2026ALPHARETTA, Ga., Feb. 24, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported fourth quarter and full-year 2025 results. "I'm very pleased with our fourth quarter and full-year results, which demonstrate meaningful progress on our strategic priorities," said David Pacitti, Avanos' chief

    2/24/26 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results

    ALPHARETTA, Ga., Feb. 16, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2025 on Tues., Feb. 24 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer.To instantly join the conference call by phone, use the following link to register close to the cal

    2/16/26 4:30:00 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. Announces Third Quarter 2025 Results

    Delivered double-digit growth in Specialty Nutrition Systems segmentClosed acquisition of Nexus Medical, providing a complementary technology for the Specialty Nutrition Systems segmentRaising and narrowing top-line guidance and adjusted EPS guidance for the full yearALPHARETTA, Ga., Nov. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported third quarter 2025 financial results. "I am pleased with our third quarter results, both operationally and commercially," said David Pacitti, Avanos' chief executive officer. Pacitti continued, "Avanos delivered double-di

    11/5/25 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Avanos Medical Inc.

    SC 13G - AVANOS MEDICAL, INC. (0001606498) (Subject)

    11/14/24 1:28:34 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Avanos Medical Inc. (Amendment)

    SC 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)

    2/14/24 11:41:02 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Avanos Medical Inc. (Amendment)

    SC 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)

    2/13/24 4:58:57 PM ET
    $AVNS
    Industrial Specialties
    Health Care